Objective: We report the distributions of multiple dimensions of bladder health and function in a population-based sample of community-dwelling women, overall and separately in women without urinary symptoms to begin to explore bladder health dimensions that may precede the onset of symptoms.
Study Design: RISE FOR HEALTH is a regionally-representative cohort study of US women aged 18 and older. Baseline surveys included the validated Bladder Health Scales/Bladder Function Indices, the 10-item Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index, and additional study items. Bladder well-being was assessed across 10 scales and bladder function across six indices. Bladder Health Scale scores were adjusted for adaptive/coping behaviors (e.g., using/carrying pads, staying close to a toilet) to account for the perceived impact of urinary symptoms on well-being. Scores for scales and indices ranged from 0 (poor well-being/function) to 100 (optimal well-being/function). We calculated summary statistics for each scale (with and without adaptive behavior adjustment) and each index in the full study population and subset of women without urinary symptoms.
Results: The mean age of 3,027 eligible participants was 49.8 years (SD 17.9). The median global Bladder Health Scale score was 72 (IQR: 56, 84) before adjustment for adaptive/coping behaviors and 55 (IQR: 34, 78) after adjustment. Median scores for the other scales ranged from 75-100 before and 61-72 after adjustment. Sixty-nine percent of participants reported using adaptive/coping behaviors, including using pads (40%), toilet mapping (58%), and staying close to a toilet (3%). The median overall Bladder Function Index score was 77 (IQR: 63, 89); individual median scores ranged from 63-68 for frequency, sensation, continence, and emptying indices to 100 for biosis/urinary tract infection and comfort indices. Among participants without reported urinary symptoms (n=700), scores were higher across all scales (unadjusted medians=88-100 and adjusted medians=82-100) and indices (medians=93-100), indicating better, but not optimal health; however, 38% of asymptomatic women reported using adaptive/coping behaviors: 11% using pads, 30% toilet mapping, and 2% staying close to a toilet.
Conclusion: We observed a wide range of bladder well-being and function in RISE participants, and high utilization of adaptive/coping behaviors. Bladder health variability and utilization of adaptive/coping behaviors was also observed in women without urinary symptoms, highlighting bladder health dimensions not captured by traditional urinary symptom tools and potentially identifying a group of women with “sub-clinical” symptoms who may be at greater risk of developing urinary symptoms. Future prospective analyses should investigate this novel group of women further.
Ariana L. SMITH, MD1 ∙ Chloe FALKE, BS2 ∙ Kyle D. RUDSER, PhD2 ∙ Gerald McGWIN, PhD3 ∙ Sonya S. BRADY, PhD4 ∙ Linda BRUBAKER, MD5 ∙ Kimberly KENTON, MD6 ∙ D. Yvette LaCOURSIERE, MD, MPH7 ∙ Cora E. LEWIS, MD8 ∙ Lisa K. LOW, PhD9 ∙ Jerry L. LOWDER, MD10 ∙ Emily S. LUKACZ, MD11 ∙ Elizabeth R. MUELLER, MD12 ∙ Diane K. NEWMAN, DNP13 ∙ Jesse NODORA, DrPH14 ∙ Alayne MARKLAND, MD15 ∙ Sara PUTNAM16 ∙ Leslie M. RICKEY, MD, MPH17 ∙ Todd ROCKWOOD, PhD18 ∙ Melissa A. SIMON, MD, PhD19 ∙ Ann STAPLETON, MD20 ∙ Camille P. VAUGHAN, MD21 ∙ Jean F. WYMAN, PhD22 ∙ Siobhan SUTCLIFFE, PhD23 ∙ for the Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium